BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15354213)

  • 1. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.
    Jamerson MH; Johnson MD; Korsmeyer SJ; Furth PA; Dickson RB
    Br J Cancer; 2004 Oct; 91(7):1372-9. PubMed ID: 15354213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Of mice and Myc: c-Myc and mammary tumorigenesis.
    Jamerson MH; Johnson MD; Dickson RB
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):27-37. PubMed ID: 15082916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
    Jäger R; Herzer U; Schenkel J; Weiher H
    Oncogene; 1997 Oct; 15(15):1787-95. PubMed ID: 9362445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.
    Shibata MA; Liu ML; Knudson MC; Shibata E; Yoshidome K; Bandey T; Korsmeyer SJ; Green JE
    EMBO J; 1999 May; 18(10):2692-701. PubMed ID: 10329616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis.
    Bosch A; Bertran SP; Lu Y; Garcia A; Jones AM; Dawson MI; Farias EF
    Breast Cancer Res; 2012 Aug; 14(4):R121. PubMed ID: 22920668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.
    Peirce SK; Chen WY
    Oncogene; 2004 Feb; 23(6):1248-55. PubMed ID: 14647416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.
    Romieu-Mourez R; Kim DW; Shin SM; Demicco EG; Landesman-Bollag E; Seldin DC; Cardiff RD; Sonenshein GE
    Mol Cell Biol; 2003 Aug; 23(16):5738-54. PubMed ID: 12897145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells.
    Nass SJ; Li M; Amundadottir LT; Furth PA; Dickson RB
    Biochem Biophys Res Commun; 1996 Oct; 227(1):248-56. PubMed ID: 8858133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
    Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
    Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency.
    Feng F; Rittling SR
    Breast Cancer Res Treat; 2000 Sep; 63(1):71-9. PubMed ID: 11079161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
    Zhang J; Li Y; Liu Q; Lu W; Bu G
    Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic co-operation in beta-cell tumorigenesis.
    Pelengaris S; Khan M
    Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax accelerates tumorigenesis in p53-deficient mice.
    Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ
    Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc functionally cooperates with Bax to induce apoptosis.
    Juin P; Hunt A; Littlewood T; Griffiths B; Swigart LB; Korsmeyer S; Evan G
    Mol Cell Biol; 2002 Sep; 22(17):6158-69. PubMed ID: 12167710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
    Strumane K; Rygiel T; van der Valk M; Collard JG
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1.
    Gauger KJ; Bassa LM; Henchey EM; Wyman J; Ser-Dolansky J; Shimono A; Schneider SS
    Mol Cancer; 2014 May; 13():117. PubMed ID: 24885183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.